No recruitment yet of participants for PH COVID-19 vaccine ‘mix and match’ trial, says DOST exec

2021-11-12 3,031

The Department of Science and Technology (DOST) said Friday, Nov. 12, that the recruitment of 3,000 participants for the country’s “Mix and Match” (MnM) study has yet to start.

READ MORE: https://mb.com.ph/2021/11/12/no-recruitment-yet-of-participants-for-ph-covid-19-vaccine-mix-and-match-trial-says-dost-exec/

Videos similaires

Clinical trial para sa ‘mix and match’ ng COVID-19 vaccines, target gawin sa Hunyo o Hulyo; DOST, magsasagawa rin ng hiwalay na pag-aaral para sa 'real world performance' ng COVID-19 vaccines

DOST, tiniyak na walang masasayang na bakuna sa clinical trial ng mix and match ng COVID-19 vaccines

Trials para sa "mix and match" ng COVID vaccines, isasagawa ng DOST | News Live

DOST, aprubado ang pagsasagawa ng dalawang pag-aaral sa bisa ng COVID-19 vaccines at sa mix-and-match ng mga bakuna

DOST, tiniyak na walang masasayang na bakuna sa clinical trial ng COVID-19 vaccine mix and match

Clinical trial para sa COVID vaccine mix and match, nagsimula na - DOST Usec. Guevara | News Live

Panayam ng Rise and Shine kay DOST USec. Rowena Guevarra kaugnay ng clinical trial ng mix and match ng COVID-19 vaccines

Clinical trial para sa ‘mix and match’ ng COVID-19 vaccines, inaasahang masisimulan sa susunod na buwan ayon sa DOST

DOST, gagamitin ang COVID-19 vaccines na mayroon na sa Pilipinas sa pag-aaral hinggil sa mix and match ng mga bakuna

DOST preparing for trials on mixing and matching COVID-19 vaccines; DOST: 4 COVID-19 vaccines approved by FDA; OCTA: NCR should remain under GCQ classification despite improving stats

Web Analytics